Dr. Sarah Marie Larson, MD

Dr. Larson practices at UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health.

Dr. Larson's NPI, 1588820955, was assigned on August 5, 2008. Dr. Larson graduated from University Of Minnesota Medical School in 2007. Dr. Larson holds California license A117249.

Dr. Larson's primary practice is UCLA Santa Monica Medical Center, at 1250 16th Street, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 319-4000.

Dr. Larson's primary practice is UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health. Dr. Larson is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Larson to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Larson practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Larson's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Larson is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Larson's licenses on file in 2 states: California and Illinois.

Dmand AI lists chronic anemia, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Larson treats.

CMS data shows 29,664 Medicare services from Dr. Larson across 27 procedure codes in 2024, for 325 Medicare patients. Medicare paid $1,169,946 for them.

CMS counts 325 Medicare patients who saw Dr. Larson in 2024. The largest group is 65 to 74, with 162 patients. 69% of them have high cholesterol, and 66% have high blood pressure. 16% are also on Medicaid. Their average risk score is 2.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Larson's median patient age at 68, with 49% women.

In 2024, Dr. Larson wrote 440 Medicare Part D claims for 88 patients. 82% of them were for generic drugs. CMS names the drug for 291 of them, across 9 drugs with 11 or more claims each, at $807,362 in total drug cost. In 2023, CMS named 388 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Larson for performance year 2024, reported as part of a group. Dr. Larson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Larson as offering telehealth.

Dmand AI links 2 papers to Dr. Larson in 2019. Dr. Larson's most frequent co-authors are Jason Tin Aye Lee, MD, Joshua Parks Sasine, MD and John Matthew Timmerman, MD.

Dmand AI links Dr. Larson to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Anemia, Sickle Cell and Anemia, Hemolytic, Congenital. Open Payments lists research payments to Dr. Larson that name 1 trial.

CMS Open Payments shows 69 general payments to Dr. Larson from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $7,009. It also lists 12 research payments totaling $7,070 from 2023 to 2025, naming 1 clinical trial.

Dr. Larson graduated from University Of Minnesota Medical School in 2007.

Dr. Larson is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.